IL93896A - Medicinal preparations containing the history of vitamin D3 for the suppression of synthesis of the parathyroid hormone and its secretion - Google Patents
Medicinal preparations containing the history of vitamin D3 for the suppression of synthesis of the parathyroid hormone and its secretionInfo
- Publication number
- IL93896A IL93896A IL9389690A IL9389690A IL93896A IL 93896 A IL93896 A IL 93896A IL 9389690 A IL9389690 A IL 9389690A IL 9389690 A IL9389690 A IL 9389690A IL 93896 A IL93896 A IL 93896A
- Authority
- IL
- Israel
- Prior art keywords
- vitamin
- composition according
- pth
- pharmaceutical composition
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/329,606 US4948789A (en) | 1989-03-28 | 1989-03-28 | Suppression of parathyroid hormone synthesis and secretion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL93896A true IL93896A (en) | 1994-10-21 |
Family
ID=23286199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9389690A IL93896A (en) | 1989-03-28 | 1990-03-26 | Medicinal preparations containing the history of vitamin D3 for the suppression of synthesis of the parathyroid hormone and its secretion |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4948789A (de) |
| EP (1) | EP0390114B1 (de) |
| JP (1) | JPH0686382B2 (de) |
| KR (1) | KR0153532B1 (de) |
| AT (1) | ATE111737T1 (de) |
| AU (1) | AU618506B2 (de) |
| CA (1) | CA2013166C (de) |
| DE (1) | DE69012620T2 (de) |
| DK (1) | DK0390114T3 (de) |
| ES (1) | ES2063852T3 (de) |
| HK (1) | HK66895A (de) |
| HU (1) | HU211597A9 (de) |
| IE (1) | IE64949B1 (de) |
| IL (1) | IL93896A (de) |
| ZA (1) | ZA902353B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2229921B (en) * | 1989-04-05 | 1992-12-16 | Chugai Pharmaceutical Co Ltd | Treatment for hyperparathyroidism with use of vitamin d derivatives |
| GB9017890D0 (en) | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| GB9220272D0 (en) * | 1992-09-25 | 1992-11-11 | Leo Pharm Prod Ltd | Chemical compounds |
| US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
| US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
| US20020183288A1 (en) * | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US20040043971A1 (en) * | 1995-04-03 | 2004-03-04 | Bone Care International, Inc. | Method of treating and preventing hyperparathyroidism with active vitamin D analogs |
| US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US6566353B2 (en) * | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
| JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化１α−ヒドロキシビタミンＤ |
| CA2420759A1 (en) * | 2000-08-30 | 2003-02-27 | Daishiro Miura | Parathyroid hormone production inhibitors containing vitamin d3 derivatives |
| US7129230B2 (en) | 2001-03-12 | 2006-10-31 | Nestec S.A. | Method and product for treating cancer in pets |
| EP1402893A4 (de) * | 2001-07-03 | 2006-02-08 | Chugai Pharmaceutical Co Ltd | Medizinische zusammensetzungen zur behandlung der sekundären nebenschilddrüsenüberfunktion und mittel zur behandlung von kardiovaskulären komplikationen in verbindung mit der behandlung der sekundären nebenschilddrüsenüberfunktion |
| US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
| US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
| US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
| US7094775B2 (en) | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0184112B1 (de) * | 1984-11-27 | 1990-05-09 | Chugai Seiyaku Kabushiki Kaisha | Vitamin D-Derivate und Verfahren zu deren Herstellung |
| US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
-
1989
- 1989-03-28 US US07/329,606 patent/US4948789A/en not_active Expired - Lifetime
-
1990
- 1990-03-22 AU AU52106/90A patent/AU618506B2/en not_active Expired
- 1990-03-23 IE IE108390A patent/IE64949B1/en not_active IP Right Cessation
- 1990-03-26 IL IL9389690A patent/IL93896A/en not_active IP Right Cessation
- 1990-03-27 KR KR1019900004135A patent/KR0153532B1/ko not_active IP Right Cessation
- 1990-03-27 ZA ZA902353A patent/ZA902353B/xx unknown
- 1990-03-27 CA CA002013166A patent/CA2013166C/en not_active Expired - Lifetime
- 1990-03-28 DK DK90105922.0T patent/DK0390114T3/da active
- 1990-03-28 DE DE69012620T patent/DE69012620T2/de not_active Expired - Lifetime
- 1990-03-28 AT AT90105922T patent/ATE111737T1/de not_active IP Right Cessation
- 1990-03-28 JP JP2080544A patent/JPH0686382B2/ja not_active Expired - Lifetime
- 1990-03-28 ES ES90105922T patent/ES2063852T3/es not_active Expired - Lifetime
- 1990-03-28 EP EP90105922A patent/EP0390114B1/de not_active Expired - Lifetime
-
1995
- 1995-05-04 HK HK66895A patent/HK66895A/xx not_active IP Right Cessation
- 1995-06-30 HU HU95P/P00670P patent/HU211597A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2063852T3 (es) | 1995-01-16 |
| CA2013166A1 (en) | 1990-09-28 |
| DK0390114T3 (da) | 1994-10-17 |
| US4948789A (en) | 1990-08-14 |
| ATE111737T1 (de) | 1994-10-15 |
| KR0153532B1 (ko) | 1998-11-16 |
| IE64949B1 (en) | 1995-09-20 |
| EP0390114B1 (de) | 1994-09-21 |
| EP0390114A2 (de) | 1990-10-03 |
| CA2013166C (en) | 2001-01-02 |
| EP0390114A3 (de) | 1991-10-30 |
| HU211597A9 (en) | 1995-12-28 |
| DE69012620T2 (de) | 1995-03-23 |
| ZA902353B (en) | 1990-12-28 |
| JPH037231A (ja) | 1991-01-14 |
| AU5210690A (en) | 1990-10-04 |
| JPH0686382B2 (ja) | 1994-11-02 |
| KR900013965A (ko) | 1990-10-22 |
| HK66895A (en) | 1995-05-12 |
| AU618506B2 (en) | 1991-12-19 |
| DE69012620D1 (de) | 1994-10-27 |
| IE901083L (en) | 1990-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0390114B1 (de) | Unterdrückung der Synthese und der Sekretion des Nebenschilddrüsenhormons mit Vitamin D3-Derivaten | |
| US6150346A (en) | Method and composition for treating or preventing osteoporosis | |
| US5063221A (en) | Treatment for hyperparathyroidism with use of vitamin d derivatives | |
| JP3529790B2 (ja) | 続発性上皮小体機能亢進症の治療のための薬剤の製造におけるビタミンｄ▲下２▼又はビタミンｄ▲下４▼誘導体の用途 | |
| Slatopolsky et al. | A new analog of calcitriol, 19-nor-1, 25-(OH) 2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia | |
| Landucci et al. | Inhibition of carrageenin‐induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2 | |
| Slatopolsky et al. | Effects of 19-nor-1, 25 (OH) 2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats | |
| KR20010093825A (ko) | 신규의 핵수용체 리간드 | |
| Mawer et al. | Metabolism of vitamin D in patients with primary biliary cirrhosis and alcoholic liver disease | |
| JP3255926B2 (ja) | 腎機能障害患者における燐酸塩過剰血症予防のための１９−ノル−ビタミンｄ化合物の使用 | |
| HUE029493T2 (en) | Preparation for treating infertility | |
| EP0215956A1 (de) | Mittel zur behandlung von hautkrankheiten | |
| EP0617959A1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| Pietrek et al. | Serum 25‐hydroxyvitamin D in patients with chronic renal disease | |
| Compston et al. | Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3. | |
| US6057308A (en) | Remedy or preventive for hyperlipemia | |
| Hahn et al. | Sequential changes in mineral metabolism and serum vitamin D metabolite concentrations produced by phenobarbital administration in the rat | |
| Sjöden et al. | Effects of 1αOHD2 on bone tissue Studies of 1αOHD2 and 1αOHD3 in normal rats and in rats treated with prednisolone | |
| JPS6140231B2 (de) | ||
| RU2000782C1 (ru) | Способ лечени больных сахарным диабетом I типа | |
| Rader et al. | Effect of treatment with parathyroid extract on bone parameters and metabolism of 3H-25-hydroxyvitamin D3 in Hypocalcemic Thyroparathyroidectomized Rats | |
| JPH0347127A (ja) | 副甲状腺機能亢進症治療剤 | |
| JPWO2003004036A1 (ja) | 二次性副甲状腺機能亢進症の治療用医薬組成物および二次性副甲状腺機能亢進症治療に伴う心血管系合併症の治療薬 | |
| JPH0136805B2 (de) | ||
| JPH0813744B2 (ja) | ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体を有効成分とする医薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |